-5%
Sensimet combines Rosiglitazone and Metformin to tackle type 2 diabetes by improving insulin action and reducing blood sugar. It’s a dynamic duo for managing glucose levels!
Rosiglitazone+Metformin is classified as an antidiabetic medication belonging to the thiazolidinedione group. It is primarily used for the treatment of type II diabetes mellitus, a condition characterized by ineffective insulin utilization in the body, leading to abnormal blood glucose levels. Type II diabetes typically affects middle-aged or older individuals.
The active ingredient in Sensimet 1mg Tablet is Rosiglitazone+Metformin, which functions by enhancing the body’s utilization of insulin. It is typically prescribed in conjunction with dietary management and regular physical exercise to regulate blood sugar levels.
While taking Rosiglitazone+Metformin, patients may experience certain side effects, including vomiting, nausea, abdominal pain, headache, upper respiratory tract infections, and muscle pain. Most of these side effects are mild and tend to resolve on their own without the need for medical intervention. However, if any side effects persist or worsen, it is advisable to consult a healthcare provider. The medication should be taken exactly as prescribed by the healthcare provider and can be taken with or without food. The specific dosage will be determined by the doctor based on the patient’s medical condition.
There are several precautions to consider when using Rosiglitazone+Metformin. It should be avoided if the patient is allergic to any of its components. Patients should inform their healthcare provider about their medical history and any other medications, including herbs and supplements, they are currently taking before starting Rosiglitazone+Metformin treatment to prevent potential interactions. Rosiglitazone+Metformin is not suitable for individuals with type 1 diabetes mellitus, a history of heart failure, or a history of diabetic ketoacidosis. Pregnant or breastfeeding individuals should consult their doctor before using this medication. It is not recommended for children under 18 years of age. Additionally, Rosiglitazone+Metformin should not be used in combination with insulin.